Drugs / LEO80122
last change Jan 2009 re-read 2 minutes ago

LEO80122

Developed for
atopic eczema · hand dermatosis · psoriasis
Investigated by
LEO Pharma

Trials 3 · a red edge is where a trial was stopped

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00764751 Sep → Dec 2008 psoriasis LEO Pharma Completed No outcome recorded
Phase 2 NCT00404196 Oct 2006 → Mar 2007 hand dermatosis LEO Pharma Completed No outcome recorded
Phase 2 NCT00392067 Oct 2006 → Jun 2007 atopic eczema LEO Pharma Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as LEO80122 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00404196
2

NCT00392067

NCT00764751